[W ashington FORM 8-A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 15 Zhi Tong Road Zhongguancun Science and Technol]
[W ashington FORM 8-A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 15 Zhi Tong Road Zhongguancun Science and Technol]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT Effective as of February 19, 2020 Amendment Amended and Restated Rights Agreement Company Rights Agent This Amendment (this “ WHEREAS, the Company and the Rights Agent have here]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT Effective as of February 19, 2020 Amendment Amended and Restated Rights Agreement Company Rights Agent This Amendment (this “ WHEREAS, the Company and the Rights Agent have here]
[Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children BEIJING, December 27, 2019--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the China Nati]
[Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children BEIJING, December 27, 2019--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the China Nati]
[Sinovac Reports Unaudited Third Quarter 2019 Financial Results BEIJING, China, Novermber 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the thi]
[Sinovac Reports Unaudited Third Quarter 2019 Financial Results BEIJING, China, Novermber 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the thi]
